Communication Can Mean More to Hypersomnia Patients Than a Label
How evolving diagnoses and unclear terminology can undermine patient trust—and what clinicians can do about it.
Category: Hypersomnias
Hypersomnias
Latest
Hypersomnias
Latest
Narcolepsy Network Appoints New Executive Director
She brings over 20 years of nonprofit leadership and personal rare disease experience to guide the patient advocacy group.
Hypersomnias
Latest
Alkermes Completes Acquisition of Avadel Pharmaceuticals, Adding LUMRYZ to Portfolio
The acquisition accelerates Alkermes’ entry into the sleep medicine market and incorporates the FDA-approved extended-release sodium oxybate treatment for narcolepsy.
Narcolepsy
Latest
The Once-Nightly, Salt-Free, Artificial Sweetener-Free Oxybate in the Works for Narcolepsy, IH
Avadel Pharmaceuticals has licensed valiloxybate from XWPharma Ltd.
Idiopathic Hypersomnia
Latest
FDA Grants Orphan Drug Designation to IH Drug Contender
A phase 3 trial is underway to evaluate the drug's efficacy and safety in adults with IH, with enrollment expected to complete by the end of 2025.
Insufficient Sleep Syndrome
Latest
Sleep Disorders and Lack of Sleep Plague Active US Military Personnel
A new study found that 85% of active duty servicemen and servicewomen have sleep disorders.
Kleine-Levin Syndrome
Latest
Kleine-Levin Syndrome Foundation Taps First Executive Director
An experienced non-profit leader and author is appointed to the first-ever professional staff role for the foundation.